Abstract:Immune associated ophthalmopathy ranks as one of the major causes of visual handicap in adults, including ocular tumor, uveitis, corneal transplantation rejection, thyroid associated ophthalmopathy, and so on.These conditions are difficult to therapy, bad prognosis, and are an urgent ophthalmic clinical problems to be solved. Immunotherapies have been playing an important role in the comprehensive therapy for immune associated ophthalmopathy. This article reviewed on this study.
